Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:EMBC NYSE:INFU NASDAQ:SKYA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$4.34-0.1%$4.23$1.59▼$5.08$181.68M1.37148,166 shs5,023 shsEMBCEmbecta$3.33-0.7%$3.24$2.77▼$15.55$197.87M0.831.58 million shs182,913 shsINFUInfuSystem$9.00-2.6%$9.26$5.38▼$11.04$182.45M1.4168,376 shs14,356 shsSKYASkyAI, Inc. Common Stock$1.20+0.4%$1.38$0.91▼$18.23$50.57M2.1447,423 shs46,897 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical-1.81%-2.69%+4.58%+9.05%+107.66%EMBCEmbecta+4.04%+5.35%+8.41%-65.75%-65.64%INFUInfuSystem+2.55%-5.13%+5.00%-12.67%+68.00%SKYASkyAI, Inc. Common Stock-4.03%+0.85%-7.75%-37.70%-79.86%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$4.34-0.1%$4.23$1.59▼$5.08$181.68M1.37148,166 shs5,023 shsEMBCEmbecta$3.33-0.7%$3.24$2.77▼$15.55$197.87M0.831.58 million shs182,913 shsINFUInfuSystem$9.00-2.6%$9.26$5.38▼$11.04$182.45M1.4168,376 shs14,356 shsSKYASkyAI, Inc. Common Stock$1.20+0.4%$1.38$0.91▼$18.23$50.57M2.1447,423 shs46,897 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical-1.81%-2.69%+4.58%+9.05%+107.66%EMBCEmbecta+4.04%+5.35%+8.41%-65.75%-65.64%INFUInfuSystem+2.55%-5.13%+5.00%-12.67%+68.00%SKYASkyAI, Inc. Common Stock-4.03%+0.85%-7.75%-37.70%-79.86%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.71Moderate Buy$6.6052.25% UpsideEMBCEmbecta 1.40Strong Sell$11.00230.83% UpsideINFUInfuSystem 2.67Moderate Buy$15.0066.69% UpsideSKYASkyAI, Inc. Common Stock 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest SKYA, EMBC, INFU, and APYX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/14/2026APYXApyx Medical Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold7/13/2026APYXApyx Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$7.006/24/2026APYXApyx Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/18/2026EMBCEmbecta Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderperform$11.00 ➝ $3.005/8/2026EMBCEmbecta Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/6/2026EMBCEmbecta Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)5/6/2026EMBCEmbecta MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$12.00 ➝ $5.005/5/2026EMBCEmbecta BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral4/21/2026SKYASkyAI, Inc. Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 7/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$52.84M3.44N/AN/A$0.39 per share11.12EMBCEmbecta$1.08B0.18$4.16 per share0.80($11.12) per share-0.30INFUInfuSystem$142.40M1.28$0.70 per share12.79$2.47 per share3.64SKYASkyAI, Inc. Common Stock$200K252.86N/AN/A$9.12 per share0.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$11.21M-$0.22N/AN/AN/A-16.40%-88.47%-14.94%8/6/2026 (Estimated)EMBCEmbecta$95.40M$1.901.761.90N/A10.73%-23.96%14.12%8/6/2026 (Estimated)INFUInfuSystem$870K$0.38150.6929.03N/A1.12%2.78%1.41%N/ASKYASkyAI, Inc. Common Stock-$282.50M-$1.63N/AN/AN/AN/A-157.91%-154.40%9/2/2026 (Estimated)Latest SKYA, EMBC, INFU, and APYX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026APYXApyx Medical-$0.06N/AN/AN/A$13.18 millionN/A8/6/2026Q3 2026EMBCEmbecta$0.26N/AN/AN/A$254.53 millionN/A5/14/2026Q1 2026SKYASkyAI, Inc. Common StockN/A-$1.19N/A-$1.19N/A$0.19 million5/7/2026Q1 2026APYXApyx Medical-$0.11-$0.05+$0.06-$0.05$10.53 million$12.49 million5/5/2026Q2 2026EMBCEmbecta$0.42$0.27-$0.15-$0.07$235.67 million$221.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/AEMBCEmbecta$0.041.20%N/A2.11%N/AINFUInfuSystemN/AN/AN/AN/AN/ASKYASkyAI, Inc. Common StockN/AN/AN/AN/AN/ALatest SKYA, EMBC, INFU, and APYX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2026EMBCEmbectaquarterly$0.011.2%5/28/20265/28/20266/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical2.685.804.79EMBCEmbectaN/A2.461.68INFUInfuSystem0.501.981.59SKYASkyAI, Inc. Common StockN/A8.288.08Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%EMBCEmbecta93.83%INFUInfuSystem71.13%SKYASkyAI, Inc. Common Stock17.17%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.90%EMBCEmbecta1.30%INFUInfuSystem10.80%SKYASkyAI, Inc. Common Stock20.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27041.91 million35.25 millionOptionableEMBCEmbecta1,85059.33 million58.56 millionOptionableINFUInfuSystem41020.18 million19.10 millionOptionableSKYASkyAI, Inc. Common Stock5542.32 million33.86 millionNot OptionableSKYA, EMBC, INFU, and APYX HeadlinesRecent News About These CompaniesSkyAI, Inc. Common Stock (NASDAQ:SKYA) Sees Large Decrease in Short Interest3 hours ago | marketbeat.comSkyAI, Inc. Common Stock (NASDAQ:SKYA) Shares Up 3.5% - Here's What HappenedJuly 10, 2026 | americanbankingnews.comSkyAI, Inc.: SkyAI Confirms Receipt of Unsolicited, Non-Binding Proposal from Forward IndustriesJune 16, 2026 | finanznachrichten.deUPDATED: Forward Industries Announces Letter of Intent to Acquire SkyAI, Inc. (SKYA)June 15, 2026 | globenewswire.comSkyAI receives unsolicited all-stock merger proposal from Forward IndustriesJune 15, 2026 | msn.comSkyAI Confirms Receipt of Unsolicited, Non-Binding Proposal from Forward IndustriesJune 15, 2026 | globenewswire.comForward Industries Announces Letter of Intent to Acquire SkyAI, Inc. (SKYA)June 15, 2026 | globenewswire.comSkyAI Inc.June 12, 2026 | money.usnews.comSharps Technology Appoints Arthur Levine as Chief Financial OfficerMay 29, 2026 | tipranks.comSharps Technology Becomes SkyAI, Inc. with New Ticker Symbol “SKYA”; Establishing Category-defining Agentic Finance Platform Serving Global SouthMay 28, 2026 | markets.businessinsider.comSharps Technology Inc: Sharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury ExecutionMay 16, 2026 | finanznachrichten.deSharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury ExecutionMay 15, 2026 | prnewswire.comSharps Technology Inc: Sharps Technology Adopts Limited Duration Stockholder Rights PlanMay 15, 2026 | finanznachrichten.deSharps Technology Adopts Limited Duration Stockholder Rights PlanMay 14, 2026 | prnewswire.comSharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury StrategyApril 7, 2026 | theglobeandmail.comSharps Technology, Inc. Reports Financial Results for 2025 with Over 2 Million SOL and Expanded Partnerships in the Solana EcosystemApril 6, 2026 | quiverquant.comQSharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana EcosystemFebruary 25, 2026 | markets.businessinsider.comSharps Technology Appoints Interim Chief Financial Officer LevineFebruary 23, 2026 | tipranks.comHoldings Ltd Falconx Sells 239,588 Shares of Sharps Technology (NASDAQ:STSS) StockFebruary 14, 2026 | insidertrades.comSharps Technology and BitGo Announce Collaboration to Advance Solana Treasury StrategyFebruary 5, 2026 | globenewswire.comSharps Technology Inc: Sharps Technology Reports Strong Solana Staking IncomeJanuary 26, 2026 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSKYA, EMBC, INFU, and APYX Company DescriptionsApyx Medical NASDAQ:APYX$4.34 -0.01 (-0.12%) As of 10:48 AM Eastern This is a fair market value price provided by Massive. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Embecta NASDAQ:EMBC$3.32 -0.03 (-0.75%) As of 10:50 AM Eastern This is a fair market value price provided by Massive. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.InfuSystem NYSE:INFU$9.00 -0.24 (-2.61%) As of 10:49 AM Eastern This is a fair market value price provided by Massive. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.SkyAI, Inc. Common Stock NASDAQ:SKYA$1.20 +0.01 (+0.42%) As of 10:27 AM EasternSkyAI Inc is developing financial technology platforms focused on users in emerging markets. Its operations include the use of stablecoin-based payment infrastructure and artificial intelligence (AI) technologies to provide financial access, educational tools, and data analysis services for users in Asia, Latin America, and Africa. The company's platform will utilize the Solana blockchain network to support digital asset and on-chain data applications. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Has Broadcom Become Too Expensive for Its AI Story? The AI Data Center Boom Is Bigger Than One Stock—These ETFs Spread the Bet Palantir's Wild Ride: Inside the Stock Wall Street Can't Agree On Revving Up Returns: Big Banks Race Through the Rate Plateau Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase Japan’s Crypto Overhaul Could Open the Door to a Wave of Institutional Money Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
